PARIS, March 25, 2026 (GLOBE NEWSWIRE) -- Following the submission of a letter of intent to the U.S. Nuclear Regulatory Commission (NRC) on 23 February 2026, newcleo has initiated pre-application engagement with the NRC to support the future licensing of its first advanced nuclear facilities in the United States. These activities relate to a 480 MWth Lead-cooled Fast Reactor (LFR) and an associated mixed-oxide (MOX) fuel fabrication facility (FFF). The fuel fabrication facility forms part of the strategic partnership announced in October 2025 between newcleo and Oklo.
The early interactions between newcleo and the NRC are intended to familiarize NRC staff with the proposed facility designs and associated safety approaches for both the LFR and the fuel fabrication facility. These discussions also support the development of regulatory plans and facilitate NRC resource and budget planning.
newcleo is pursuing the necessary NRC licenses for the development of the LFR and the fuel fabrication facility, as well as for the possession, use, and transportation of associated nuclear materials. This early engagement represents an important first step toward establishing a clear and predictable regulatory pathway for the approval of newcleo's technologies in the United States.
Stefano Buono, founder and CEO of newcleo said: "Our early engagement with the NRC enables a structured and transparent dialogue covering both the fuel fabrication and LFR facilities. This process is essential to ensure that our future applications are aligned with NRC requirements from the outset. We welcome the constructive interactions we've had with the NRC to this point, and we look forward to establishing a clear licensing timeline for our U.S. projects, including the advanced nuclear fuel manufacturing infrastructure that we plan to deploy in partnership with Oklo."
About newcleo
newcleo is an innovative nuclear energy company developing Advanced Modular Reactors (AMRs) cooled by liquid lead, and nuclear fuel from reprocessed nuclear waste, with the goal of delivering abundant, competitive, low-carbon energy. The company was founded by physicist-entrepreneur Stefano Buono following the USD 3.9 billion sale of his previous venture - NASDAQ-listed nuclear medicine company Advanced Accelerator Applications - to Novartis. With over USD 80 million in revenue in 2024, over USD 750 million in private funding, and more than 900 highly skilled employees across Europe and the US, the company has built a network of over 100 industry partnerships and supports its growth through the targeted acquisition and vertical integration of key companies in the nuclear supply chain. Visit www.newcleo.com
Forward-Looking Statements
This press release contains certain forward-looking statements. These forward-looking statements are based on management's current expectations, estimates, forecasts and projections, as well as beliefs and assumptions made by management, and include statements that are not historical facts. Forward-looking statements generally may be identified by the use of words such as "believe," "expect," "anticipate," "intend," "plan," "may," "should," "will," "would," "could," "potential," "future," "continue," "strategy," "opportunity" and similar expressions. These forward-looking statements include, but are not limited to, statements regarding newcleo's business strategy, plans, objectives, market opportunities, growth prospects, development and commercialization of technologies, partnerships, regulatory matters, operational performance, financial outlook and other future events or developments. Forward-looking statements are subject to risks, uncertainties and assumptions, many of which are beyond newcleo's control, that could cause actual results to differ materially from those expressed in or implied by such statements. Forward-looking statements speak only as of the date they are made. Readers are cautioned not to place undue reliance on forward-looking statements, and newcleo undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law. No assurance can be given that any future results, events or circumstances reflected in the forward-looking statements will be achieved or occur.
For media enquiries
Newcleo press office
media@newcleo.com
European media enquiries
newcleo@brunswickgroup.com
US media enquiries
newcleo@icrinc.com
